137 related articles for article (PubMed ID: 21886896)
1. Design, synthesis and biological evaluation of new 5,5-diarylhydantoin derivatives as selective cyclooxygenase-2 inhibitors.
Zarghi A; Javid FS; Ghodsi R; Dadrass OG; Daraei B; Hedayati M
Sci Pharm; 2011; 79(3):449-60. PubMed ID: 21886896
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of New 2-Phenyl-4H-chromen-4-one Derivatives as Selective Cyclooxygenase-2 Inhibitors.
Zarghi A; Kakhki S
Sci Pharm; 2015; 83(1):15-26. PubMed ID: 26839798
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of 5-oxo-1,4,5,6,7,8 hexahydroquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Zarghi A; Sabakhi I; Topuzyan V; Hajimahdi Z; Daraie B
Iran J Pharm Res; 2014; 13(Suppl):61-9. PubMed ID: 24711830
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
Rao PN; Uddin MJ; Knaus EE
J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.
Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Uddin MJ; Rao PN; Knaus EE
Bioorg Med Chem; 2004 Nov; 12(22):5929-40. PubMed ID: 15498669
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective COX-2 Inhibitors.
Bayanati M; Daraei B; Zarghi A
Anticancer Agents Med Chem; 2023; 23(2):192-200. PubMed ID: 35692149
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of 1,3-diarylprop-2-en-1-ones : a novel class of cyclooxygenase-2 inhibitors.
Zarghi A; Arfaee S; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Apr; 14(8):2600-5. PubMed ID: 16356730
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Biological Evaluation of4-(Imidazolylmethyl)-2-(4-methylsulfonyl phenyl)-Quinoline Derivatives as Selective COX-2 Inhibitors and In-vitro Anti-breast Cancer Agents.
Ghodsi R; Azizi E; Zarghi A
Iran J Pharm Res; 2016; 15(1):169-77. PubMed ID: 27610157
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (β-lactams) as selective cyclooxygenase-2 inhibitors.
Arefi H; Naderi N; Shemirani ABI; Kiani Falavarjani M; Azami Movahed M; Zarghi A
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900293. PubMed ID: 31917485
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfonamide pharmacophore by a sulfonylazide bioisostere.
Uddin MJ; Rao PN; Knaus EE
Bioorg Med Chem; 2003 Nov; 11(23):5273-80. PubMed ID: 14604691
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new rofecoxib analogs as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the methanesulfonyl pharmacophore by a N-acetylsulfonamido bioisostere.
Zarghi A; Rao PN; Knaus EE
J Pharm Pharm Sci; 2007; 10(2):159-67. PubMed ID: 17706175
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Biological Evaluation of New 1, 4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors.
Sabakhi I; Topuzyan V; Hajimahdi Z; Daraei B; Arefi H; Zarghi A
Iran J Pharm Res; 2015; 14(4):1087-93. PubMed ID: 26664375
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-
Movahed MA; Abbasi FK; Rajabi M; Abedi N; Naderi N; Daraei B; Zarghi A
Med Chem Res; 2023; 32(5):856-868. PubMed ID: 37056461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
